BACE1 and γ‐secretase are the most important targets for candidate drugs of AD and previous studies showed the rescue effects on Aβ production treated with BSI (BACE1 inhibitor) in familial AD patient iPSC‐derived neurons.12, 40. Here, BACE1 is linked to Alzheimer disease.